| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12253-014-9761-2 |
| P698 | PubMed publication ID | 24789683 |
| P2093 | author name string | Li Jiang | |
| Wei Tang | |||
| Yongyong Tang | |||
| P2860 | cites work | TUSC4/NPRL2, a novel PDK1-interacting protein, inhibits PDK1 tyrosine phosphorylation and its downstream signaling | Q24311862 |
| HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro | Q24336517 | ||
| Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo | Q24625463 | ||
| Cancer statistics, 2008 | Q27860585 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium | Q28138149 | ||
| Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions | Q28251400 | ||
| Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma. | Q33257003 | ||
| Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer | Q33535501 | ||
| NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway | Q33654122 | ||
| Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. | Q34349241 | ||
| Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas | Q34417634 | ||
| Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers | Q34935968 | ||
| Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma | Q36380333 | ||
| From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma | Q37154789 | ||
| Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene | Q40543079 | ||
| RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma | Q40577439 | ||
| Matrix metalloproteinases | Q41366074 | ||
| Microsatellite DNA analysis does not distinguish malignant from benign pleural effusions | Q46914650 | ||
| The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor. | Q51775587 | ||
| Microsatellite analysis of induced sputum DNA in patients with lung cancer in heavy smokers and in healthy subjects. | Q53026019 | ||
| Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas. | Q53456720 | ||
| [Effect on retardation of G2/M phase in esophageal carcinoma cells transfected with CHK1 and CHK2 shRNA after irradiation]. | Q53576349 | ||
| Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. | Q53635252 | ||
| Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value | Q78019699 | ||
| NPRL2 gene expression in the progression of colon tumors | Q85226639 | ||
| NPRL2 is an independent prognostic factor of osteosarcoma | Q85900308 | ||
| P433 | issue | 4 | |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 829-837 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Pathology Oncology Research | Q26842743 |
| P1476 | title | Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features | |
| P478 | volume | 20 |
| Q26741367 | Conserved regulators of Rag GTPases orchestrate amino acid-dependent TORC1 signaling |
| Q90798961 | NPRL2 promotes docetaxel chemoresistance in castration resistant prostate cancer cells by regulating autophagy through the mTOR pathway |
| Q88720559 | PLIN3 is up-regulated and correlates with poor prognosis in clear cell renal cell carcinoma |
| Q35803423 | SEA you later alli-GATOR--a dynamic regulator of the TORC1 stress response pathway |
Search more.